Private company
Assenagon Asset Management S.A.
Last updated Oct 21, 2026.
Overview
- HeadquartersN41
Corporate structure
Assenagon Asset Management S.A. sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Assenagon Asset Management S.A. N4
- GYRE THERAPEUTICS, INC. Stake · Winston-Salem, North Carolina, United States
- Minerva Neurosciences (United States) Stake · Waltham
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.
Filings
25 filings to the SEC since October 2021: 25 other. The latest 20:
- Oct 15, 202613F-HR EDGAR
- Aug 21, 202613F-HR/A EDGAR
- Aug 14, 2026N-PX EDGAR
- Jul 8, 202613F-HR EDGAR
- Apr 20, 202613F-HR EDGAR
- Jan 9, 202613F-HR EDGAR
- Oct 7, 202513F-HR EDGAR
- Aug 1, 2025N-PX EDGAR
- Jul 11, 202513F-HR EDGAR
- Apr 15, 202513F-HR EDGAR
- Jan 14, 202513F-HR EDGAR
- Oct 23, 202413F-HR EDGAR
- Aug 19, 2024N-PX EDGAR
- Jul 18, 202413F-HR EDGAR
- Apr 24, 202413F-HR EDGAR
- Jan 17, 202413F-HR EDGAR
- Nov 6, 202313F-HR EDGAR
- Jul 25, 202313F-HR EDGAR
- Apr 18, 202313F-HR EDGAR
- Jan 12, 202313F-HR EDGAR
The 25 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Assenagon Asset Management S.A. has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).
- GYRE THERAPEUTICS, INC.SC 13G Jan 18, 20222
- Minerva Neurosciences (United States)SC 13G Nov 24, 20213
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3